Cargando…
Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin
BACKGROUND: The chemotherapy-resistance of triple-negative breast cancer (TNBC) remains a major challenge. The Nek2B kinase and β-catenin serve as crucial regulators of mitotic processes. The aim of this study was to test the correlation between Nek2B and TNBC chemotherapy sensitivity, and to determ...
Autores principales: | Shen, Honghong, Yan, Wenpeng, Yuan, Jinyang, Wang, Ziyue, Wang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556028/ https://www.ncbi.nlm.nih.gov/pubmed/31174562 http://dx.doi.org/10.1186/s13046-019-1231-y |
Ejemplares similares
-
NEK2 promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathway
por: Guo, Dong, et al.
Publicado: (2023) -
Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling
por: Yin, Lina, et al.
Publicado: (2016) -
Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1
por: Mbom, Bertrade C., et al.
Publicado: (2014) -
Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer
por: Ryu, Won-Ji, et al.
Publicado: (2020) -
Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer
por: Xu, Tie, et al.
Publicado: (2020)